This filing reports a Form 3, Initial Statement of Beneficial Ownership, for Abby Macnish Niven, Chief Financial Officer of ALTERITY THERAPEUTICS LTD. The report, dated April 9, 2026, details holdings in the company under the ticker symbol ATHE. It indicates indirect ownership of 454,545 ordinary shares through CASAM I...

This filing reports initial ownership of MiNK Therapeutics, Inc. (INKT) common stock by Melissa Orilall, the Principal Financial Officer. The filing indicates that Ms. Orilall, through her spouse, holds 222 shares of common stock. This is an initial disclosure of beneficial ownership, as indicated by the Form 3 filing ...

This filing reports initial ownership of MiNK Therapeutics, Inc. (INKT) common stock by Melissa Orilall, the Principal Financial Officer. The filing indicates that Ms. Orilall, through her spouse, holds 222 shares of common stock. This is an initial disclosure of beneficial ownership, as indicated by the Form 3 filing ...

This filing details a Power of Attorney granted by Mark Pavao, a director of Coya Therapeutics, Inc., to a group of individuals including Arun Swaminathan, David Snyder, Daniel Porco, Christopher Williams, and Chase Newman. The appointed attorneys-in-fact are authorized to execute and file various securities and owners...

This filing, a Form 3, reports the initial ownership of securities by Polina Ravzin, VP Finance at Evogene Ltd. It details the grant and vesting schedules for several stock options. Specifically, options granted on March 8, 2023, March 5, 2025, and March 4, 2026, vest quarterly over four years. The filing also includes...